-
-
-
-
-
-
-
PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology
-
-
-
-
-
-
-
PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patented Long-Acting Ketamine Program
-
-
-
-
-
-
-
PharmaTher receives FDA approval for ketamine product KETARx
-
-
-
-
-
-
-
PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases
-
-
417,488 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

